Skip to main content
Equibles
CANN logo

CANN · TREES Corp (Colorado)

Track CANN — free

Use CANN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CANN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.02 +0.00 (+7.73%) At close · Oct 21
Rebalance outlook locked
Going-concern doubt — flagged Nov 8, 2024

Substantial doubt about the company's ability to continue as a going concern.

“The Company expects our operating losses to continue into the foreseeable future as we continue to execute our acquisition and growth strategy. As a result, the Company has concluded that there is substantial doubt about its ability to continue as a going concern. The Company's unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.”
View the 10-Q filed Nov 8, 2024
Market Cap
$2.11M
Shares
108.75M
Volume · Oct 21 12.37K Avg daily vol (3M) 34.97K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.02 Open$0.02 Day$0.02–0.02 52W close$0.00–0.05 Avg vol 30d23K Short int2K · 0.0% float · 1.0d Short vol1% DataJan 2020–Oct 2026 Filing10-Q · Nov 8

Up next

Latest filing: 10-Q
filed Nov 8, 2024

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$14.50M
Trailing 12 months
Net income (TTM)
−$5.38M
Trailing 12 months
Revenue growth YoY
-19.5%
Year over year
Operating margin
-8.7%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$14.91M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-8.4%
Year over year · fewer shares
Price change (1Y)
-61.3%
Trailing year
Short interest
—
Latest settlement
View all 122 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Weak Sentiment Neutral Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 16.7 · calm Equity put/call 0.52
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −21%
below
Price vs 50-day avg +3%
above
RSI (14) 50
neutral
MACD trend Negative
52-week position 39%
mid-range
Momentum
relative strength
Weak
1-month return +13%
trailing
6-month return −28%
trailing
YTD return −44%
this year
Relative strength −35%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Distributing
-50% holders QoQ
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.00% of float · ▼ -83.5% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
1 holders — near 3-yr low, contrarian setup
Fundamentals
Weak
Revenue growth +35%
Y/Y
Gross margin -0%
contracting
EPS growth +40%
Y/Y
Free cash flow $-1.2M
Balance sheet $14.1M
net debt
Quant / Vol
risk profile
Very High
Volatility 1407%
annualized · 1-yr
Max drawdown −100%
past year
ATR 24.6%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
2 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−21% Bearish
Price vs 50-day avg
+3% Bullish
RSI (14)
50 Neutral
MACD trend
Negative Bearish
52-week position
39% Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Distributing
-50% holders QoQ
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.00% of float · ▼ -83.5% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
1 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $0 Now $0 · 39% Range high $0
vs 200-day avg -21% vs 50-day avg +3%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Drug Manufacturers - Specialty & Generic — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
CANN
TREES Corp (Colorado)
this stock
$2.11M -44.4% +34.9% — 0.0%
TAK
Takeda Pharmaceutical Co Ltd
 $64.15B +27.8% — — 0.1%
GALDY
Galderma Group AG
 $49.23B +1.9% — — 0.0%
TEVA
Teva Pharmaceutical Industries Ltd
 $46.21B +30.2% +4.3% 65.0 2.6%
HLN
Haleon plc
 $44.06B -0.9% — — 0.6%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
1
% held
0.0%
Net QoQ
-10.0K sh
Top holder
Wealth Preservation Advis…
Held Float
View
Short & Settlement
Short Interest Falling
Shares short
2.2K
Days to cover
1.0d
Change
-10.9K sh
View
Short Volume
Short vol %
1%
As of
Oct 21, 2026
Short Total
View
Fails to Deliver
FTD shares
14.3K
Value
$428
As of
Mar 30, 2026
View
Off-Exchange
Off-exchange %
100.0%
Week of
Sep 14, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$18.1M
Net income (FY)
$-7.1M
EPS diluted
$-0.06
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 22, 2025
This year
0
View
Exempt Offerings
Offering
$6.9M
Filed
Apr 26, 2021
View

Performance

5D 20D 120D MTD YTD
CANN -11.0% +12.7% -27.5% +20.4% -44.4%
SPY +0.5% +0.7% +7.6% +1.4% +13.4%
vs SPY -11.4% +12.0% -35.1% +19.0% -57.8%
Key facts CIK 1477009 CUSIP 36930V100 Visit website Investor relations